Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
650,117.100000 Euro
Forbid offers above base price:
Request Reference:
AD 3089-2023 Aquisição de Pertuzumab + Trastuzumab
Request Name:
AD 3089-2023 Aquisição de Pertuzumab 60-80 mg/ml + Trastuzumab 60-40 mg/ml Sol inj Fr 10-15 ml SC, para o CHTMAD, EPE.
Phase:
Tendering Phase
State:
Awarded
Description:
AD 3089-2023 Aquisição de Pertuzumab 60-80 mg/ml + Trastuzumab 60-40 mg/ml Sol inj Fr 10-15 ml SC, para o CHTMAD, EPE.
Procedure Type:
VortalGOV - Direct Award (ECP)
Lot Name
Lot Base Price
Expected Duration
lote 1
52,875.100000 Euro
5
(
Months
)
lote 2
597,242.000000 Euro
5
(
Months
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Av. da Noruega-Lordelo 5000-508 Lordelo Vila Real PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
8/4/2023 11:21 AM
(UTC +1 hour)
Due datetime for receiving replies:
8/7/2023 4:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
AD 3089-2023 Anexo III.xlsx
AD 3089-2023 Anexo III.xlsx
Download
AD 3089-2023 Convite e CE.pdf
AD 3089-2023 Convite e CE.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
Lote 1
Articulado
1.1.1
Lote 1
Articulado
*
(Os valores indicados não incluem o IVA)
Preço Total
Total without VAT
0,000000
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
110680867
Internal Reference
Description
Pertuzumab 80 mg/ml + Trastuzumab 40 mg/ml Sol inj Fr 15 ml SC
Qty
10,000000
Unit
UNID
Price per Unit
Total
1.2
Lote 2
Articulado
1.2.1
Lote 2
Articulado
*
(Os valores indicados não incluem o IVA)
Preço Total
Total without VAT
0,000000
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
110680868
Internal Reference
Description
Pertuzumab 60 mg/ml + Trastuzumab 60 mg/ml Sol inj Fr 10 ml SC
Qty
200,000000
Unit
UNID
Price per Unit
Total
Evaluation
Evaluation
Evaluation General Settings
Evaluation General Settings
Evaluation guideline
LowestPrice
Evaluation Method
Manual
Evaluation Items
Evaluation Items
Name
Lot
Regras de avaliação para o lote 1
1 - lote 1
Regras de avaliação para o lote 2
2 - lote 2
Critérios de Adjudicação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Critérios de Adjudicação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...